Business Briefs: Mylan issues drug recall

Share with others:


Print Email Read Later

Mylan issues drug recall

Mylan Inc. issued a nationwide recall of 1,184 cartons of diltiazem HCL extended-release capsules made at its Morgantown, W.Va., plant because of out-of-specification test results, according to a Food and Drug Administration enforcement report. The capsules, packaged in blister cards, are used to treat high blood pressure and chest pain known as angina. 

GNC approves dividend

Board mem­bers for Pitts­burgh-based GNC Hold­ings Inc. board have au­tho­rized a third-quar­ter cash div­i­dend of 16 cents per share of the com­pany’s com­mon stock. The div­i­dend will be paid on or about Sept. 26 for those hold­ing stock as of Sept. 12.

Local earnings

Al­le­gheny Val­ley Ban­corp said net in­come for the sec­ond quar­ter dou­bled to $905,000, or 91 cents per share, up from $436,000, or 45 cents, in the same three months last year as net in­ter­est in­come and nonin­ter­est in­come rose.

Molson Coors CEO retiring 

Molson Coors Brewing President and CEO Peter S. Swinburn, 61, will retire at the end of the year. The brewing company said Friday that he will be succeeded in the posts by Mark R. Hunter, who currently serves as CEO and president of Molson Coors Europe.

Lyft expanding into NYC

The on-demand ride-sharing app Lyft planned to start limited service in New York City on Friday night after reaching agreement with officials to resolve regulatory issues that prompted a lawsuit by the state.

Durable goods orders rise

Orders for long-lasting manufactured goods rebounded in June after a May decline. Orders for durable goods increased 0.7 percent in June on a seasonally adjusted basis following a 1 percent decline in May, the Commerce Department reported Friday.

From staff and wire reports


Join the conversation:

Commenting policy | How to report abuse
To report inappropriate comments, abuse and/or repeat offenders, please send an email to socialmedia@post-gazette.com and include a link to the article and a copy of the comment. Your report will be reviewed in a timely manner. Thank you.
Commenting policy | How to report abuse

Advertisement
Advertisement
Advertisement

You have 2 remaining free articles this month

Try unlimited digital access

If you are an existing subscriber,
link your account for free access. Start here

You’ve reached the limit of free articles this month.

To continue unlimited reading

If you are an existing subscriber,
link your account for free access. Start here